查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1426497

即时PCR、数位 PCR、端点 PCR 2024 年全球市场报告

Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

即时PCR、数位 PCR 和终点 PCR 的市场规模预计在未来几年将显着增长。预计到 2028 年将以 9.4% 的复合年增长率 (CAGR) 增长至 549.5 亿美元。预测期内的预期增长可归因于分子诊断的扩展、传染病检查的增长、基因检测需求的增加、调查和法医学的市场渗透以及快速照护现场PCR 解决方案的采用。预测期内预计的主要趋势包括数位化验的出现、多重 PCR 的进步、向数位 PCR 技术的迁移、高通量系统的自动化以及 PCR 平台的小型化。

感染疾病的预期成长预计将推动即时PCR、数位 PCR 和端点 PCR 市场的成长。利用PCR技术可以有效对抗细菌、病毒、真菌、寄生虫等病原微生物生长引起的感染疾病。即时PCR、数位PCR和终点PCR在定量特定病原体或其遗传物质、监测疾病进展以及快速诊断HIV、肝炎、呼吸道病毒和结核病等感染疾病方面发挥重要作用。例如，联合国爱滋病规划署报告称，到 2022 年，美国爱滋病毒感染者人数将增至 3,900 万人。这比 2020 年的 3,770 万人增加了 3.17%，2022 年报告的新爱滋病毒感染人数约为 130 万人。美国疾病管制与预防中心指出，结核病病例数将从 2021 年的 7,874 例增加到 2022 年的 8,300 例。因此，感染疾病发生率的增加正在推动 PCR 市场的成长。

由于慢性病的增加，即时PCR、数位 PCR 和终点 PCR 的市场预计将扩大。慢性疾病通常会持续很长时间并随着时间的推移而恶化，这使得它们成为 PCR 应用的重要焦点。即时PCR透过检测与癌症、糖尿病和病毒感染等疾病相关的特定 DNA 或 RNA 标记物，有助于早期、准确地诊断慢性疾病。世界卫生组织报告称，全球每年有4,100万人死亡，其中74%死于非传染性疾病，其中1,790万人死于心血管疾病，1,790万人死于癌症，930万人死亡，410万人死于慢性病。呼吸道疾病，以及 200 万人死于糖尿病。因此，慢性病盛行率的增加已成为即时PCR、数位 PCR 和终点 PCR 市场的主要驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球即时PCR、数位 PCR、端点 PCR 市场，依产品、效能和预测细分，2018-2023、2023-2028、2033
  • 装置
  • 耗材和试剂
  • 软体和服务
  • 全球即时PCR、数位 PCR、端点 PCR 市场，按技术、性能和预测细分，2018-2023、2023-2028、2033
  • 定量的
  • 终点聚合酵素链锁反应(PCR)
  • 数位的
  • 全球即时PCR、数位 PCR、端点 PCR 市场，按应用细分、实际和预测，2018-2023、2023-2028、2033
  • 临床
  • 研究
  • 法医学
  • 其他用途
  • 全球即时PCR、数位 PCR、端点 PCR 市场、最终用户细分、性能和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊断实验室
  • 製药
  • 生物技术
  • 合约研究组织

第 7 章 区域与国家分析

  • 全球即时PCR、数位 PCR、端点 PCR 市场，按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球即时PCR、数位 PCR、端点 PCR 市场，按国家、实际和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 即时PCR、数位PCR和端点PCR市场的竞争形势
  • 即时PCR、数位PCR、端点PCR市场公司概况
    • F. Hoffmann La Roche Ltd.
    • Merck &Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章 其他大型创新公司

  • Becton Dickinson and Co.
  • GE HealthCare Technologies Inc.
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Eppendorf Group
  • Promega Corporation
  • Meridian Bioscience Inc.
  • Takara Bio Inc.
  • Cole-Parmer Instrument Company LLC
  • Bioneer Corporation
  • Enzo Life Sciences Inc.
  • Analytik Jena AG
  • Fluidigm Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13509

Real-time PCR (polymerase chain reaction), digital PCR, and endpoint PCR are distinct techniques in molecular biology and genetic analysis employed for amplifying and analyzing DNA samples. Real-time PCR is a laboratory technique used to amplify and quantify DNA or RNA molecules. Digital PCR is the third generation of PCR that enables precise quantification by segregating a sample into numerous isolated compartments. Endpoint PCR, also known as conventional PCR, is a fundamental molecular biology technique used to amplify a specific DNA sequence from a sample. These PCR techniques are utilized in various clinical applications, including bacteria detection, DNA fingerprinting, and genetic disorder diagnosis.

The main products associated with real-time PCR, digital PCR, and endpoint PCR include instruments, consumables and reagents, software, and services. Instruments refer to devices, tools, or equipment designed for measurement, analysis, manipulation, or control of physical, chemical, or biological phenomena. Various technologies, such as quantitative, endpoint PCR, and digital PCR, are used for clinical, research, forensic, and other applications, with different end-users including hospitals, diagnostic labs, pharmaceutical and biotechnology companies, and contract research organizations.

The real-time PCR, digital PCR and end-point PCR market research report is one of a series of new reports from The Business Research Company that provides real-time PCR, digital PCR and end-point PCR market statistics, including real-time PCR, digital PCR and end-point PCR industry global market size, regional shares, competitors with a real-time PCR, digital PCR and end-point PCR market share, detailed real-time PCR, digital PCR and end-point PCR market segments, market trends and opportunities, and any further data you may need to thrive in the real-time PCR, digital PCR and end-point PCR industry. This real-time PCR, digital PCR and end-point PCR market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The real-time pcr, digital pcr and end-point pcr market size has grown strongly in recent years. It will grow from $35.11 billion in 2023 to $38.37 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The increase observed in the historical period can be attributed to the standardization of PCR protocols, the role of PCR techniques in personalized medicine, their contribution to drug discovery and development, and the adoption of these techniques in forensic and paternity testing.

The real-time pcr, digital pcr and end-point pcr market size is expected to see strong growth in the next few years. It will grow to $54.95 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The anticipated growth in the forecast period can be attributed to the expansion of molecular diagnostics, the growth in infectious disease testing, increasing demand for genetic testing, market penetration in research and forensics, and the adoption of rapid point-of-care PCR solutions. Major trends expected in the forecast period involve the emergence of digital assays, advancements in multiplex PCR, a shift towards digital PCR technology, the automation of high-throughput systems, and the miniaturization of PCR platforms.

The anticipated rise in infectious diseases is set to drive the growth of the real-time PCR, digital PCR, and end-point PCR markets. Infectious diseases, caused by the proliferation of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, can be effectively addressed using PCR technologies. Real-time PCR, digital PCR, and end-point PCR play crucial roles in quantifying specific pathogens or their genetic material, monitoring disease progression, and swiftly diagnosing infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, UNAIDS reported a global increase in the population living with HIV to 39 million in 2022, representing a 3.17% rise from 37.7 million in 2020, with approximately 1.3 million new HIV infections reported in 2022. Moreover, in the United States, the Centers for Disease Control and Prevention noted a rise in tuberculosis cases to 8,300 in 2022 from 7,874 in 2021. Thus, the escalating incidence of infectious diseases is a driving force behind the growth of the PCR markets.

The growth of chronic diseases is poised to propel the real-time PCR, digital PCR, and end-point PCR markets. Chronic diseases, persistent over an extended period and often worsening over time, are a significant focus for PCR applications. Real-time PCR aids in the early and accurate diagnosis of chronic conditions by detecting specific DNA or RNA markers associated with diseases such as cancer, diabetes, and viral infections. The World Health Organization reported 41 million deaths globally annually, with 74% attributed to non-communicable diseases, including 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the increasing prevalence of chronic diseases is a key driver for the real-time PCR, digital PCR, and end-point PCR markets.

A potential challenge lies in the declining demand for PCR testing for COVID-19, which may restrict market growth. The real-time RT-PCR test, commonly used for COVID-19 detection, faces challenges such as false-negative and false-positive results due to various factors. The declining nationwide rate of PCR testing, as reported in Australia with a daily average dropping from approximately 280,220 tests to 250,000 tests, may impact the market negatively. Consequently, the decreasing demand for PCR testing for COVID-19 poses a hindrance to the growth of the real-time PCR, digital PCR, and end-point PCR markets.

Key players in the real-time PCR, digital PCR, and end-point PCR markets are actively pursuing the development of innovative products, leveraging advanced technologies such as digital polymerase chain reaction (dPCR). This cutting-edge biotechnological refinement of conventional PCR methods enables the direct quantification and clonal amplification of nucleic acid strands, encompassing DNA, cDNA, or RNA. Notably, major companies are at the forefront of adopting dPCR technology to gain a deeper understanding of patients' conditions, whether related to cancer, genetic diseases, or infections. An illustrative example is Roche Diagnostics, a prominent US-based manufacturer of medicines and medical devices, which unveiled the next-generation Digital LightCycler System in August 2022. Specifically designed for the early detection and treatment of various chronic and genetic disorders, this advanced system introduces automation to workflow and data management. It eliminates the need for external calculations, software, and processors. Boasting three nano well plate configurations, six advanced optical channels, and 5x concentrated DNA and RNA master mixes, the Digital LightCycler System ensures high sensitivity and precision. This addition enhances Roche's diagnostic platforms, offering advanced technology, clinical applications, customization and flexibility, along with streamlined workflow automation.

In June 2021, Hologic Inc., a US-based medical technology company, completed the acquisition of Mobidiag Oy Ltd. for a substantial $795 million. This acquisition is positioned to fortify and expand Hologic's diagnostic businesses globally, leveraging Mobidiag's expertise in providing multiplex capability, particularly in fast-growing acute care adjacencies. The collaboration between the two companies aims to offer a high-throughput point-of-care growth platform, facilitating rapid treatment decisions during patient diagnosis. Mobidiag Oy Ltd., headquartered in Finland, specializes in the development and marketing of PCR-based tests for infectious diseases, including high-impact areas such as COVID-19, influenza, and antibiotic-resistant bacteria.

Major companies operating in the real-time pcr, digital pcr and end-point pcr market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMerieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc. , Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG , Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time pcr, digital pcr and end-point pcr market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the real-time pcr, digital pcr and end-point pcr market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The real-time PCR, digital PCR, and end-point PCR market include revenues earned by entities by providing services such as quantitative analysis, real-time monitoring, high sensitivity and specificity, gene expression analysis, absolute quantification, rare event detection, qualitative detection, and molecular cloning. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time PCR, digital PCR, and end-point PCR market also include sales of thermal cyclers, fluorescent probes, quantitative data output, standard curves, real-time PCR reagents, partitioning chips or plates, digital PCR instruments, and PCR master mixes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on real-time PCR, digital PCR and end-point PCR market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for real-time pcr, digital pcr and end-point pcr? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The real-time pcr, digital pcr and end-point pcr market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Instruments; Consumables And Reagents; Software And Services
  • 2) By Technology: Quantitative; End-Point Polymerase Chain Reaction (PCR); Digital
  • 3) By Applications: Clinical; Research; Forensic; Other Applications
  • 4) By End User: Hospital; Diagnostic Labs; Pharma; Biotech; Contract Research Organizations
  • Companies Mentioned: F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Real-Time PCR, Digital PCR And End-Point PCR Market Characteristics

3. Real-Time PCR, Digital PCR And End-Point PCR Market Trends And Strategies

4. Real-Time PCR, Digital PCR And End-Point PCR Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Real-Time PCR, Digital PCR And End-Point PCR Market Size and Growth

  • 5.1. Global Real-Time PCR, Digital PCR And End-Point PCR Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Real-Time PCR, Digital PCR And End-Point PCR Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Real-Time PCR, Digital PCR And End-Point PCR Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Real-Time PCR, Digital PCR And End-Point PCR Market Segmentation

  • 6.1. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Consumables And Reagents
  • Software And Services
  • 6.2. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Quantitative
  • End-Point Polymerase Chain Reaction (PCR)
  • Digital
  • 6.3. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinical
  • Research
  • Forensic
  • Other Applications
  • 6.4. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Diagnostic Labs
  • Pharma
  • Biotech
  • Contract Research Organizations

7. Real-Time PCR, Digital PCR And End-Point PCR Market Regional And Country Analysis

  • 7.1. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Real-Time PCR, Digital PCR And End-Point PCR Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market

  • 8.1. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Real-Time PCR, Digital PCR And End-Point PCR Market

  • 9.1. China Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 9.2. China Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Real-Time PCR, Digital PCR And End-Point PCR Market

  • 10.1. India Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Real-Time PCR, Digital PCR And End-Point PCR Market

  • 11.1. Japan Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 11.2. Japan Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Real-Time PCR, Digital PCR And End-Point PCR Market

  • 12.1. Australia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Real-Time PCR, Digital PCR And End-Point PCR Market

  • 13.1. Indonesia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market

  • 14.1. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 14.2. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market

  • 15.1. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 15.2. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Real-Time PCR, Digital PCR And End-Point PCR Market

  • 16.1. UK Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Real-Time PCR, Digital PCR And End-Point PCR Market

  • 17.1. Germany Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Real-Time PCR, Digital PCR And End-Point PCR Market

  • 18.5. France Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Real-Time PCR, Digital PCR And End-Point PCR Market

  • 19.9. Italy Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Real-Time PCR, Digital PCR And End-Point PCR Market

  • 20.13. Spain Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market

  • 21.1. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 21.2. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Real-Time PCR, Digital PCR And End-Point PCR Market

  • 22.1. Russia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Real-Time PCR, Digital PCR And End-Point PCR Market

  • 23.1. North America Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 23.2. North America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Real-Time PCR, Digital PCR And End-Point PCR Market

  • 24.1. USA Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 24.2. USA Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Real-Time PCR, Digital PCR And End-Point PCR Market

  • 25.1. Canada Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 25.2. Canada Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Real-Time PCR, Digital PCR And End-Point PCR Market

  • 26.1. South America Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 26.2. South America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Real-Time PCR, Digital PCR And End-Point PCR Market

  • 27.1. Brazil Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market

  • 28.1. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 28.2. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Real-Time PCR, Digital PCR And End-Point PCR Market

  • 29.1. Africa Real-Time PCR, Digital PCR And End-Point PCR Market Overview
  • 29.2. Africa Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Real-Time PCR, Digital PCR And End-Point PCR Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Real-Time PCR, Digital PCR And End-Point PCR Market Competitive Landscape And Company Profiles

  • 30.1. Real-Time PCR, Digital PCR And End-Point PCR Market Competitive Landscape
  • 30.2. Real-Time PCR, Digital PCR And End-Point PCR Market Company Profiles
    • 30.2.1. F. Hoffmann La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Real-Time PCR, Digital PCR And End-Point PCR Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Co.
  • 31.2. GE HealthCare Technologies Inc.
  • 31.3. Agilent Technologies Inc.
  • 31.4. bioMerieux S.A.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. QIAGEN N.V.
  • 31.7. Eppendorf Group
  • 31.8. Promega Corporation
  • 31.9. Meridian Bioscience Inc.
  • 31.10. Takara Bio Inc.
  • 31.11. Cole-Parmer Instrument Company LLC
  • 31.12. Bioneer Corporation
  • 31.13. Enzo Life Sciences Inc.
  • 31.14. Analytik Jena AG
  • 31.15. Fluidigm Corporation

32. Global Real-Time PCR, Digital PCR And End-Point PCR Market Competitive Benchmarking

33. Global Real-Time PCR, Digital PCR And End-Point PCR Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Real-Time PCR, Digital PCR And End-Point PCR Market

35. Real-Time PCR, Digital PCR And End-Point PCR Market Future Outlook and Potential Analysis

  • 35.1 Real-Time PCR, Digital PCR And End-Point PCR Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Real-Time PCR, Digital PCR And End-Point PCR Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Real-Time PCR, Digital PCR And End-Point PCR Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer